Pfizer Said to Weigh Sale of Pump Unit Acquired in Hospira DealBy , , and
Drugmaker could fetch about $2 billion from transaction
Sale process is at very early stage, plans could change
Pfizer Inc. is weighing a sale of the pumps and devices business it acquired in last year’s purchase of Hospira Inc., people with knowledge of the matter said.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.